Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Study of Octohydroaminoacridine Succinate Tablets in Patients With Alzheimer's Disease

The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2011 by Changchun Huayang High-tech Co., Ltd.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
Beijing Bionovo Medicine Development Co., Ltd.
Information provided by (Responsible Party):
Changchun Huayang High-tech Co., Ltd
ClinicalTrials.gov Identifier:
NCT01569516
First received: March 30, 2012
Last updated: April 6, 2012
Last verified: May 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: October 2012
  Estimated Primary Completion Date: July 2012 (Final data collection date for primary outcome measure)